V Liu

Summary

Affiliation: Stanford University
Country: USA

Publications

  1. ncbi Adverse outcomes associated with delayed intensive care unit transfers in an integrated healthcare system
    Vincent Liu
    Division of Pulmonary and Critical Care Medicine, Stanford University, Stanford, CA 94305, USA
    J Hosp Med 7:224-30. 2012
  2. ncbi Pulmonary toxicity associated with erlotinib
    Vincent Liu
    Thoracic Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Chest 132:1042-4. 2007
  3. ncbi A multi-drug regimen for respiratory syncytial virus and parainfluenza virus infections in adult lung and heart-lung transplant recipients
    V Liu
    Heart Lung and Lung Transplantation Program, Division of Pulmonary and Critical Care Medicine, Stanford University School of Medicine, Stanford, California, USA
    Transpl Infect Dis 12:38-44. 2010
  4. ncbi Increasing lung allocation scores predict worsened survival among lung transplant recipients
    V Liu
    Division of Pulmonary and Critical Care Medicine, Stanford University, Stanford, CA, USA
    Am J Transplant 10:915-20. 2010
  5. ncbi Length of stay predictions: improvements through the use of automated laboratory and comorbidity variables
    Vincent Liu
    Division of Pulmonary and Critical Care Medicine, Stanford University, Stanford, CA 94305, USA
    Med Care 48:739-44. 2010
  6. ncbi Racial disparities in survival after lung transplantation
    Vincent Liu
    Division of Pulmonary and Critical Care Medicine, Stanford University, 300 Pasteur Drive, Stanford, CA 94305, USA
    Arch Surg 146:286-93. 2011
  7. ncbi Persistent racial disparities in survival after heart transplantation
    Vincent Liu
    Divisions of Pulmonary and Critical Care, Stanford University, CA, USA
    Circulation 123:1642-9. 2011
  8. ncbi Systematic review: the effects of growth hormone on athletic performance
    Hau Liu
    Santa Clara Valley Medical Center, San Jose, California 95128, USA
    Ann Intern Med 148:747-58. 2008
  9. ncbi Case records of the Massachusetts General Hospital. Case 19-2008. A 63-year-old HIV-positive man with cutaneous Merkel-cell carcinoma
    Paul M Busse
    Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, USA
    N Engl J Med 358:2717-23. 2008

Detail Information

Publications9

  1. ncbi Adverse outcomes associated with delayed intensive care unit transfers in an integrated healthcare system
    Vincent Liu
    Division of Pulmonary and Critical Care Medicine, Stanford University, Stanford, CA 94305, USA
    J Hosp Med 7:224-30. 2012
    ..Patients with intensive care unit (ICU) transfers from hospital wards have higher mortality than those directly admitted from the emergency department...
  2. ncbi Pulmonary toxicity associated with erlotinib
    Vincent Liu
    Thoracic Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Chest 132:1042-4. 2007
    ..Similar to reports in patients receiving gefitinib, those with pathologic findings of UIP on resected lung specimens or known pulmonary fibrosis may be at particular risk for erlotinib pulmonary toxicity...
  3. ncbi A multi-drug regimen for respiratory syncytial virus and parainfluenza virus infections in adult lung and heart-lung transplant recipients
    V Liu
    Heart Lung and Lung Transplantation Program, Division of Pulmonary and Critical Care Medicine, Stanford University School of Medicine, Stanford, California, USA
    Transpl Infect Dis 12:38-44. 2010
    ..We evaluated the utility of a multi-drug protocol for the treatment of RSV- and PIV-related infections...
  4. ncbi Increasing lung allocation scores predict worsened survival among lung transplant recipients
    V Liu
    Division of Pulmonary and Critical Care Medicine, Stanford University, Stanford, CA, USA
    Am J Transplant 10:915-20. 2010
    ..By specific diagnosis, an increased hazard was observed in patients with COPD with LAS > or = 80, as well as those with IPF with LAS > or = 60...
  5. ncbi Length of stay predictions: improvements through the use of automated laboratory and comorbidity variables
    Vincent Liu
    Division of Pulmonary and Critical Care Medicine, Stanford University, Stanford, CA 94305, USA
    Med Care 48:739-44. 2010
    ..Most methods for risk-adjusting LOS are limited by the use of only administrative data. Recent studies suggest that adding automated clinical data to these models improves performance...
  6. ncbi Racial disparities in survival after lung transplantation
    Vincent Liu
    Division of Pulmonary and Critical Care Medicine, Stanford University, 300 Pasteur Drive, Stanford, CA 94305, USA
    Arch Surg 146:286-93. 2011
    ..Racial disparities have not been comprehensively evaluated among recipients of lung transplantation...
  7. ncbi Persistent racial disparities in survival after heart transplantation
    Vincent Liu
    Divisions of Pulmonary and Critical Care, Stanford University, CA, USA
    Circulation 123:1642-9. 2011
    ..Racial and ethnic disparities are well documented in many areas of health care, but have not been comprehensively evaluated among recipients of heart transplants...
  8. ncbi Systematic review: the effects of growth hormone on athletic performance
    Hau Liu
    Santa Clara Valley Medical Center, San Jose, California 95128, USA
    Ann Intern Med 148:747-58. 2008
    ..Human growth hormone is reportedly used to enhance athletic performance, although its safety and efficacy for this purpose are poorly understood...
  9. ncbi Case records of the Massachusetts General Hospital. Case 19-2008. A 63-year-old HIV-positive man with cutaneous Merkel-cell carcinoma
    Paul M Busse
    Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, USA
    N Engl J Med 358:2717-23. 2008